These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 94402

  • 1. Effects of probucol on hyperlipidemic patients with cardiac allografts.
    Anderson JL, Schroeder JS.
    J Cardiovasc Pharmacol; 1979; 1(3):353-65. PubMed ID: 94402
    [Abstract] [Full Text] [Related]

  • 2. Effect of probucol in hyperlipidemic patients during two years of administration.
    Parsons WB.
    Am Heart J; 1978 Aug; 96(2):213-7. PubMed ID: 354360
    [Abstract] [Full Text] [Related]

  • 3. Comparative study of bezafibrate and probucol in hyperlipidaemia.
    Páez Moreno JP, González G.
    Curr Med Res Opin; 1989 Aug; 11(8):523-32. PubMed ID: 2680288
    [Abstract] [Full Text] [Related]

  • 4. Diet and probucol in lowering cholesterol concentrations. Additive effects on plasma cholesterol concentrations in patients with familial type ii hyperlipoproteinemia.
    LeLorier J, DuBreuil-Quidoz S, Lussier-Cacan S, Huang YS, Davignon J.
    Arch Intern Med; 1977 Oct; 137(10):1429-34. PubMed ID: 335998
    [Abstract] [Full Text] [Related]

  • 5. A comparison of cholestyramine and probucol in the treatment of familial hypercholesterolaemia.
    Jones DB, Simpson HC, Slaughter P, Lousley S, Carter RD, Cobbe SM, Mann JI.
    Atherosclerosis; 1984 Oct; 53(1):1-7. PubMed ID: 6388586
    [Abstract] [Full Text] [Related]

  • 6. A multicenter comparison of lovastatin and probucol for treatment of severe primary hypercholesterolemia. The Lovastatin Study Group IV.
    Am J Cardiol; 1990 Sep 18; 66(8):22B-30B. PubMed ID: 2206033
    [Abstract] [Full Text] [Related]

  • 7. Effect of probucol on hyperlipidemia in patients with nephrotic syndrome.
    Iida H, Izumino K, Asaka M, Fujita M, Nishino A, Sasayama S.
    Nephron; 1987 Sep 18; 47(4):280-3. PubMed ID: 3696330
    [Abstract] [Full Text] [Related]

  • 8. Probucol (Lorelco) in treatment of hyperlipemia.
    Murphy BF.
    JAMA; 1977 Dec 05; 238(23):2537-8. PubMed ID: 199758
    [Abstract] [Full Text] [Related]

  • 9. Effects of combined probucol-colestipol treatment for familial hypercholesterolemia and coronary artery disease.
    Kuo PT, Wilson AC, Kostis JB, Moreyra AE.
    Am J Cardiol; 1986 Jun 27; 57(16):43H-48H. PubMed ID: 3524177
    [Abstract] [Full Text] [Related]

  • 10. Long-term use of probucol in the multifactorial primary prevention of vascular disease.
    Miettinen TA, Huttunen JK, Naukkarinen V, Strandberg T, Vanhanen H.
    Am J Cardiol; 1986 Jun 27; 57(16):49H-54H. PubMed ID: 2873740
    [Abstract] [Full Text] [Related]

  • 11. Effect of probucol on plasma lipids and lipoproteins in type IIb hyperlipoproteinemia.
    Hunninghake DB, Bell C, Olson L.
    Atherosclerosis; 1980 Nov 27; 37(3):469-74. PubMed ID: 7458992
    [Abstract] [Full Text] [Related]

  • 12. Double-blind, placebo-controlled, cross-over trial of probucol in heterozygous familial hypercholesterolaemia.
    Durrington PN, Miller JP.
    Atherosclerosis; 1985 May 27; 55(2):187-94. PubMed ID: 3890872
    [Abstract] [Full Text] [Related]

  • 13. [Evaluation of the effect of probucol on blood lipids].
    Giannini SD, Forti N, Ziliotto EE.
    Arq Bras Cardiol; 1981 Feb 27; 36(2):139-42. PubMed ID: 7325835
    [No Abstract] [Full Text] [Related]

  • 14. Controlled studies of the efficacy and safety of combined probucol-colestipol therapy.
    Dujovne CA, Krehbiel P, Chernoff SB.
    Am J Cardiol; 1986 Jun 27; 57(16):36H-42H. PubMed ID: 3524176
    [Abstract] [Full Text] [Related]

  • 15. The long-term effects of probucol on serum lipid levels.
    McCaughan D.
    Arch Intern Med; 1981 Oct 27; 141(11):1428-32. PubMed ID: 7025778
    [Abstract] [Full Text] [Related]

  • 16. Probucol reduces lysophosphatidylcholines in low-density lipoprotein.
    Yoshinari M, Shi AH, Yoshizumi H, Wakisaka M, Iwase M, Fujishima M.
    Eur J Clin Pharmacol; 2000 Oct 27; 55(11-12):787-92. PubMed ID: 10805055
    [Abstract] [Full Text] [Related]

  • 17. Effect of probucol on triton induced hyperlipidemias in CFY rats.
    Krishnamurthy A, Thapar GS, Shridhar DR.
    Artery; 1985 Oct 27; 13(2):87-94. PubMed ID: 4084069
    [Abstract] [Full Text] [Related]

  • 18. Treatment of the hyperlipidemia of the nephrotic syndrome: a controlled trial.
    Valeri A, Gelfand J, Blum C, Appel GB.
    Am J Kidney Dis; 1986 Dec 27; 8(6):388-96. PubMed ID: 3544820
    [Abstract] [Full Text] [Related]

  • 19. Post-marketing surveillance of probucol (Sinlestal) in Japan.
    Kosasayama A, Yoshida M, Okada S.
    Artery; 1992 Dec 27; 19(3):147-61. PubMed ID: 1637256
    [Abstract] [Full Text] [Related]

  • 20. Low-dose colestipol plus probucol for hypercholesterolemia.
    Dujovne CA, Chernoff SB, Krehbiel P, Jackson B, DeCoursey S, Taylor H.
    Am J Cardiol; 1984 Jun 01; 53(11):1514-8. PubMed ID: 6375337
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.